Catheter Precision, Inc. (VTAK)
$0.16+$0.01 (+3.63%) Latest session
Philip J. Anderson - OfficerCatheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
https://www.catheterprecision.comSEC filings for VTAK on EDGAR
No Form 4 activity for VTAK in the last 90 days.
11 Form 4 filings on record, the earliest from Aug 12, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David A. Jenkins - Officer | Grant or award | Options (Right to Buy) | 40,000 | $0.00 | - | |
| Philip J. Anderson - Officer | Grant or award | Options (Right to Buy) | 40,000 | $0.00 | - | |
| Andrew Arno - Director | Grant or award | Options (Right to Buy) | 40,000 | $0.00 | - | |
| James Joseph Caruso - Director | Grant or award | Options (Right to Buy) | 40,000 | $0.00 | - | |
| Martin J. Colombatto - Director | Grant or award | Options (Right to Buy) | 40,000 | $0.00 | - | |
| David A. Jenkins - Officer | Other | Series J Preferred Stock | 2,491 | - | - | |
| David A. Jenkins - Officer | Other | Series J Preferred Stock | 6,998 | - | - | |
| David A. Jenkins - Officer | Other | Series M Common Stock Purchase Warrant | 170,000 | $1.56 | $265K | |
| David A. Jenkins - Officer | Other | Series M Common Stock Purchase Warrant | 170,000 | $1.56 | $265K | |
| David A. Jenkins - Officer | Grant or award | Options (Right to Buy) | 500,000 | $0.00 | - | |
| James Joseph Caruso | Grant or award | Options (Right to Buy) | 50,000 | $0.00 | - | |
| Andrew Arno | Grant or award | Options (Right to Buy) | 50,000 | $0.00 | - | |
| Martin J. Colombatto | Grant or award | Options (Right to Buy) | 50,000 | $0.00 | - |
Catheter Precision, Inc. (VTAK) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-03-30. The full record for VTAK runs to 11 Form 4 filings, the earliest from 2025-08-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of VTAK were filed in the last 90 days.
No insider sales of VTAK were filed in the last 90 days.
This page tracks VTAK Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add VTAK to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
